EMD-51952

Single-particle
2.1 Å
EMD-51952
3D View Gallery
Deposition: 29/10/2024
Map released: 02/04/2025
Last modified: 09/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-51952

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9h94 summary report (pdf.gz) Map-9h94 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC5a) from a yeast expression system.

EMD-51952

Single-particle
2.1 Å
EMD-51952
3D View Gallery
Deposition: 29/10/2024
Map released: 02/04/2025
Last modified: 09/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Poliovirus 2
Sample: Poliovirus 2
Fitted models: 9h94

Deposition Authors: Bahar MW, Sherry L , Stonehouse NJ, Rowlands DJ, Fry EE, Stuart DI
Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
Sherry L , Grehan K , Bahar MW, Swanson JJ, Fox H, Matthews S, Carlyle S, Qin L, Porta C, Wilkinson S, Robb S, Clark N, Liddell J, Fry EE, Stuart DI, Macadam AJ, Rowlands DJ, Stonehouse NJ
(2025) NPJ Vaccines , 10 , 64 - 64
PUBMED: 40164627
DOI: doi:10.1038/s41541-025-01111-2
ISSN: 2059-0105
Grant Support: